The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Canakinumab

Australian Public Assessment Report

AusPAR

AusPAR: Canakinumab [PDF, 1.26 MB]

AusPAR: Canakinumab [Word, 2.28 MB]

Attachment: Product information: Canakinumab [PDF, 280.71 KB]

Attachment: Product information: Canakinumab [Word, 143.83 KB]

Attachment: Extract from the Clinical Evaluation Report: Canakinumab [PDF, 1.89 MB]

Attachment: Extract from the Clinical Evaluation Report: Canakinumab [Word, 2.41 MB]

Device/Product Name

Ilaris

Active ingredients

Canakinumab

AusPAR Date

25 November 2014

Published

14 January 2015

Submission Number

PM-2013-01501-1-3

Submission Type

Extension of indications

Decision

Approved